Oxford BioDynamics (LON:OBD) Stock Price Crosses Below Fifty Day Moving Average – Should You Sell?

Oxford BioDynamics Plc (LON:OBD) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 0.21 and traded as low as GBX 0.20. Oxford BioDynamics shares last traded at GBX 0.20, with a volume of 554,075 shares changing hands.

Oxford BioDynamics Trading Down 5.3%

The firm has a fifty day moving average of GBX 0.21 and a 200-day moving average of GBX 0.25. The company has a debt-to-equity ratio of 457.97, a quick ratio of 2.80 and a current ratio of 0.88. The stock has a market capitalization of £7.72 million, a price-to-earnings ratio of -0.23 and a beta of 0.42.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.